Evaluation of complement (C3) inhibition in vitro by drugs used in the management of bronchial asthma.
D000293:Adolescent; D000328:Adult; D000420:Albuterol / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000276:immunology*; D003167:Complement Activation / Q000187:drug effects*; D003176:Complement C3 / Q000276:immunology; D004205:Cromolyn Sodium / Q000494:pharmacology; D003864:Depression, Chemical; D004049:Diethylcarbamazine / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology
D003176:Complement C3; D000628:Aminophylline; D004205:Cromolyn Sodium; D000420:Albuterol; D004049:Diethylcarbamazine; D006854:Hydrocortisone